Cleared Traditional

K142923 - TraumaCad Mobile Release 1.0

K142923 is an FDA 510(k) clearance for TraumaCad Mobile Release 1.0, manufactured by Voyant Health, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 148-day FDA review.

K142923 · Voyant Health, Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2015
Decision
148d
Days
Class 2
Risk

K142923 is an FDA 510(k) clearance for the TraumaCad Mobile Release 1.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Voyant Health, Ltd. (Petach-Tikva, IL). The FDA issued a Cleared decision on March 5, 2015 after a review of 148 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Voyant Health, Ltd. devices

FDA 510(k) Submission Details - K142923

510(k) Number K142923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 2014
Decision Date March 05, 2015
Days to Decision 148 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 107d · This submission: 148d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2163
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K142923.
Blackford Analysis Registration Product Family
K142337 · Blackford Analysis, Ltd. · Mar 2015
DR Systems Zero Download 3D Viewer (Z3D)
K143318 · Dr Systems, Inc. · Mar 2015
VIEWING CLIENT MOBILE
K141536 · Axon Medical Technologies Corp. · Mar 2015
Vitrea, Version 7.0 Medical Image Processing Software
K150258 · Vital Images, Inc. · Mar 2015
GE EchoPAC
K150085 · Ge Vingmed Ultrasound AS · Mar 2015
Syngo X-workplace SW VD10
K143319 · Siemens Medi Cal Solutions, Inc. · Feb 2015